Healthpeak Properties (NYSE:DOC) Releases FY 2026 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.730-1.770 for the period, compared to the consensus EPS estimate of 1.750. The company issued revenue guidance of -.

Healthpeak Properties Stock Performance

Shares of NYSE:DOC traded down $0.49 during mid-day trading on Thursday, reaching $21.30. The company had a trading volume of 3,376,725 shares, compared to its average volume of 8,615,680. Healthpeak Properties has a one year low of $15.70 and a one year high of $22.95. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The company’s 50-day moving average price is $21.12 and its 200-day moving average price is $18.76. The firm has a market cap of $14.68 billion, a price-to-earnings ratio of 60.87, a PEG ratio of 3.36 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. The business had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a return on equity of 2.87% and a net margin of 8.24%.The business’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the business posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, equities research analysts anticipate that Healthpeak Properties will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.7%. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

Analyst Upgrades and Downgrades

DOC has been the topic of several recent research reports. Raymond James Financial assumed coverage on shares of Healthpeak Properties in a report on Wednesday, June 17th. They set a “market perform” rating on the stock. Cantor Fitzgerald upped their price target on shares of Healthpeak Properties from $20.00 to $23.00 and gave the company a “neutral” rating in a research note on Thursday. Wells Fargo & Company raised their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 15th. Robert W. Baird boosted their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. Finally, Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Four analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $20.97.

Insider Activity at Healthpeak Properties

In related news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Healthpeak Properties

Institutional investors and hedge funds have recently bought and sold shares of the stock. Invesco Ltd. grew its holdings in shares of Healthpeak Properties by 9.9% in the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock worth $294,244,000 after purchasing an additional 1,648,012 shares during the last quarter. Corient Private Wealth LLC boosted its position in Healthpeak Properties by 33.3% during the 4th quarter. Corient Private Wealth LLC now owns 90,463 shares of the real estate investment trust’s stock valued at $1,455,000 after buying an additional 22,583 shares during the period. Ameriflex Group Inc. purchased a new stake in Healthpeak Properties during the 4th quarter valued at $89,000. Mercer Global Advisors Inc. ADV grew its holdings in Healthpeak Properties by 53.2% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 54,872 shares of the real estate investment trust’s stock worth $882,000 after acquiring an additional 19,065 shares during the last quarter. Finally, Vident Advisory LLC increased its position in shares of Healthpeak Properties by 3.4% in the fourth quarter. Vident Advisory LLC now owns 96,523 shares of the real estate investment trust’s stock valued at $1,552,000 after acquiring an additional 3,129 shares during the period. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.